Interview with Psyched Wellness CEO, Jeff Stevens | Psyched Wellness takes ‘key step’ by beginning its 14-day oral toxicity study of AME-1 April 28, 2021 Read More »
Interview with Psyched Wellness CEO, Jeff Stevens | Psyched Wellness shares become DTC eligible in ‘major milestone’ April 15, 2021 Read More »
TCI CEO Interview w/ Jeffrey Stevens of Psyched Wellness 🇨🇦CSE: PSYC 🇺🇸 OTC:OTCQB: PSYCF 🇩🇪FRA: 5U9 March 11, 2021 Read More »
Interview w/ Professor Nutt. He explains why Amanita Muscaria is exciting for psychedelics. February 25, 2021 Read More »
